Growth Metrics

Emergent BioSolutions (EBS) Treasury Shares (2016 - 2026)

Emergent BioSolutions has reported Treasury Shares over the past 15 years, most recently at $261.6 million for Q1 2026.

  • For Q1 2026, Treasury Shares rose 14.89% year-over-year to $261.6 million; the TTM value through Mar 2026 reached $261.6 million, up 14.89%, while the annual FY2025 figure was $252.6 million, 10.94% up from the prior year.
  • Treasury Shares for Q1 2026 was $9.6 million at Emergent BioSolutions, up from $8.7 million in the prior quarter.
  • Over five years, Treasury Shares peaked at $9.6 million in Q1 2026 and troughed at $4.9 million in Q1 2022.
  • A 5-year average of $6.2 million and a median of $5.6 million in 2022 define the central range for Treasury Shares.
  • Biggest five-year swings in Treasury Shares: soared 475.0% in 2022 and later changed 0.0% in 2023.
  • Year by year, Treasury Shares stood at $227.7 million in 2022, then changed by 0.0% to $227.7 million in 2023, then changed by 0.0% to $227.7 million in 2024, then grew by 10.94% to $252.6 million in 2025, then rose by 3.56% to $261.6 million in 2026.
  • Business Quant data shows Treasury Shares for EBS at $261.6 million in Q1 2026, $252.6 million in Q4 2025, and $243.5 million in Q3 2025.